Fusion Antibodies (FAB) Competitors GBX 4.20 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades FAB vs. RLM, NSCI, OPTI, ONC, SNG, CIZ, BVX, IMM, GENF, and ROQShould you be buying Fusion Antibodies stock or one of its competitors? The main competitors of Fusion Antibodies include Realm Therapeutics (RLM), NetScientific (NSCI), OptiBiotix Health (OPTI), Oncimmune (ONC), Synairgen (SNG), Cizzle Biotechnology (CIZ), BiVictriX Therapeutics (BVX), ImmuPharma (IMM), Genflow Biosciences (GENF), and Roquefort Therapeutics (ROQ). These companies are all part of the "biotechnology" industry. Fusion Antibodies vs. Realm Therapeutics NetScientific OptiBiotix Health Oncimmune Synairgen Cizzle Biotechnology BiVictriX Therapeutics ImmuPharma Genflow Biosciences Roquefort Therapeutics Realm Therapeutics (LON:RLM) and Fusion Antibodies (LON:FAB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations. Do institutionals and insiders believe in RLM or FAB? 21.0% of Fusion Antibodies shares are owned by institutional investors. 11.4% of Fusion Antibodies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend RLM or FAB? Given Realm Therapeutics' higher possible upside, equities analysts clearly believe Realm Therapeutics is more favorable than Fusion Antibodies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Realm Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AFusion Antibodies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community favor RLM or FAB? Realm Therapeutics received 139 more outperform votes than Fusion Antibodies when rated by MarketBeat users. Likewise, 71.75% of users gave Realm Therapeutics an outperform vote while only 68.35% of users gave Fusion Antibodies an outperform vote. CompanyUnderperformOutperformRealm TherapeuticsOutperform Votes19371.75% Underperform Votes7628.25% Fusion AntibodiesOutperform Votes5468.35% Underperform Votes2531.65% Does the media favor RLM or FAB? In the previous week, Fusion Antibodies' average media sentiment score of 0.67 beat Realm Therapeutics' score of 0.00 indicating that Fusion Antibodies is being referred to more favorably in the news media. Company Overall Sentiment Realm Therapeutics Neutral Fusion Antibodies Positive Is RLM or FAB more profitable? Realm Therapeutics has a net margin of 0.00% compared to Fusion Antibodies' net margin of -195.95%. Realm Therapeutics' return on equity of 0.00% beat Fusion Antibodies' return on equity.Company Net Margins Return on Equity Return on Assets Realm TherapeuticsN/A N/A N/A Fusion Antibodies -195.95%-152.68%-63.78% Which has higher earnings and valuation, RLM or FAB? Realm Therapeutics has higher earnings, but lower revenue than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRealm Therapeutics£501.92K0.00N/A-£17.50N/AFusion Antibodies£1.14M3.51-£2.19M-£0.04-105.00 SummaryRealm Therapeutics beats Fusion Antibodies on 7 of the 12 factors compared between the two stocks. Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Get Fusion Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for FAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FAB vs. The Competition Export to ExcelMetricFusion AntibodiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£4.01M£158.40M£5.41B£1.60BDividend YieldN/A3.39%5.15%10.93%P/E Ratio-105.00348.23113.591,755.31Price / Sales3.5119,806.471,480.95232,682.53Price / Cash9.0211.3039.8336.19Price / Book2.107.514.642.88Net Income-£2.19M-£18.90M£119.13M£145.32M7 Day Performance2.44%-0.05%0.78%0.11%1 Month Performance2.44%2.54%5.66%-0.11%1 Year Performance-16.42%28.34%36.85%15.48% Fusion Antibodies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FABFusion AntibodiesN/AGBX 4.20flatN/A-20.1%£4.01M£1.14M-105.0048RLMRealm TherapeuticsN/AN/AN/AN/A£13.41M£501,919.00-0.66N/ANSCINetScientificN/AN/AN/A+2.9%£12.81M£1.45M-486.3626OPTIOptiBiotix HealthN/AGBX 12.50+4.2%N/A-68.2%£12.24M£1.26M-416.671News CoverageGap DownONCOncimmuneN/AGBX 14.79-1.4%N/A-4.3%£10.97M£1.21M-493.0052News CoverageGap DownHigh Trading VolumeSNGSynairgenN/AGBX 4.50-2.6%N/A-33.8%£9.06M£79,000.00-150.0034Gap UpCIZCizzle BiotechnologyN/AGBX 2.10flatN/A+11.2%£8.32M£25,000.00-210.004Gap DownBVXBiVictriX TherapeuticsN/AN/AN/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeIMMImmuPharmaN/AGBX 1.71-6.6%N/A-6.4%£7.10M£94,819.00-170.5013Gap DownGENFGenflow BiosciencesN/AGBX 1.80-2.7%N/A+17.6%£6.30MN/A-180.005ROQRoquefort TherapeuticsN/AGBX 3.95+6.8%N/A-26.7%£5.10M£637.00-395.009High Trading Volume Related Companies and Tools Related Companies Realm Therapeutics Alternatives NetScientific Alternatives OptiBiotix Health Alternatives Oncimmune Alternatives Synairgen Alternatives Cizzle Biotechnology Alternatives BiVictriX Therapeutics Alternatives ImmuPharma Alternatives Genflow Biosciences Alternatives Roquefort Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FAB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FAB Stock Alerts